A major player in the metal industry, Vedanta Limited announced on Friday that it would employ the oversubscription option in Hindustan Zinc Limited’s ongoing offer for sale (issue) to the extent of over 1.21 crore equity shares, or 0.29%, in addition to the 5.14 crore equity shares, which represent 1.22% of the company’s total issued […]
Hindustan Zinc OFS: Vedanta Plans To Exercise Its Subscription Option Read More »
Pierre Fabre Laboratories has received a put option offer from Jubilant Biosys Innovative Research Services Pte Limited, Singapore, a division of Jubilant Biosys Limited, a fully owned subsidiary of Jubilant Pharmova Limited. The acquisition of an 80% stock part in a new firm to be founded in France is proposed in this offer, which would
Jubilant Pharmova To Invest In MNC Pierre Fabre’s French R&D Centre Via New Unit Read More »
August saw a persistent sell-off by foreign investors in the Indian equities markets, unloading shares valued at Rs 21,201 crore as a result of the termination of the yen carry trade, US recession worries, and ongoing geopolitical tensions. According to data from the depositories, this followed inflows of Rs 26,565 crore in June and Rs
In August, FPIs Turned Net Sellers, And Drew Out ₹21,201 Cr From Stocks Read More »
In India, exchange-traded funds, or ETFs, are becoming more popular. As of July 30, 2024, the assets under management (AUM) in exchange-traded funds (ETFs) had increased to Rs 8.11 trillion from Rs 1.88 trillion on February 29, 2020. Individual investor participation is also increasing, even though many readers will soon point out that this jump
How ETFs Are A Useful Tool For Investors And Positional Traders Read More »
Recent claims made by Hindenburg Research have raised questions about India’s regulatory environment and severely damaged the reputation of the Securities and Exchange Board of India (SEBI). This issue raises concerns about possible political repercussions within the largest democracy in the world, in addition to regulatory scrutiny. Reputed for its scathing analyses of big business,
Hindenburg Intensifies Its Assault Against Adani Read More »
Curious about the future price targets for SBI shares? The current price of SBI shares is ₹821.20. In this discussion, we’ll delve into detailed insights into the projected price targets for SBI from 2024 to 2030. As a leading public sector bank in India, SBI’s share price garners significant interest from investors. Various factors influence
SBI Share Price Target 2024, 2025, 2026 To 2030 and Full Details Read More »
Vi (Vodafone Idea) is an Indian telecommunications company. Vi share price on NSE as of 19 August 2024 is 15.78 INR. On this page, you will find Vi Share Price Target 2024, 2025, 2026, 2027 to 2030 as well as Vodafone Idea share price target tomorrow, Vodafone Idea share price target 2025, Vodafone Idea share
Vi Share Price Target 2024, 2025 to 2030 Prediction Read More »
IDFC First Bank, formerly known as IDFC Bank, is a subsidiary of the IDFC Group and is listed on both the NSE and BSE. This post explores IDFC First Bank share price targets for 2024, 2025, and 2030. IDFC First Bank Share Price on NSE as of 19 August 2024 is 71.74 INR. IDFC Ltd
IDFC First Bank Share Price Target 2024, 2025, 2026 to 2030 and Prediction Read More »
The Innovative Car IPO is a fixed-price offering valued at Rs 11.99 crores. The 10.25 lakh shares are being issued fully anew. The subscription period for the Resourceful Automobile IPO begins on August 22, 2024, and ends on August 26, 2024. On Tuesday, August 27, 2024, the allocation for the Resourceful Automobile IPO is anticipated
Resourceful Automobile IPO Date, Price, GMP Read More »
Ferroalloys, such as ferro silicon, high-carbon ferrochrome, low-carbon silico manganese, high-carbon ferro manganese, and high-carbon ferrochrome, are sold by QVC Exports. It also deals in raw materials used in the production of steel. The company buys the final goods, which are various ferroalloy categories, and sells them to local and foreign steel makers. It also
QVC Exports IPO Date, Price, GMP, And Review Read More »
We strongly advise against making investment decisions based solely on the target prices mentioned on this website. These target prices are merely predictions, and investing in the stock market inherently involves risk. The information provided on this site is intended for informational and educational purposes only and should not be considered financial advice or recommendations for any stock.